Skip to main content
TTY Biopharm Company Limited (TPEX:4105)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
75.60
+0.40 (0.53%)
May 14, 2025, 2:31 PM CST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cancer Drugs
2.40B
Log In
Log In
Log In
Log In
Cancer Drugs Growth
-1.21%
Log In
Log In
Log In
Log In
Anti-infective Drugs
1.22B
Log In
Log In
Log In
Log In
Anti-infective Drugs Growth
20.35%
Log In
Log In
Log In
Log In
Investment
1.12B
Log In
Log In
Log In
Log In
Investment Growth
37.00%
Log In
Log In
Log In
Log In
Export Sales and OEM
936.49M
Log In
Log In
Log In
Log In
Export Sales and OEM Growth
17.55%
Log In
Log In
Log In
Log In
Medical Insurance
186.34M
Log In
Log In
Log In
Log In
Medical Insurance Growth
-51.71%
Log In
Log In
Log In
Log In
Other
35.23M
Log In
Log In
Log In
Log In
Other Growth
-46.16%
Log In
Log In
Log In
Log In
Critical Care
-
Log In
Log In
Log In
Log In
Critical Care Growth
-
Log In
Log In
Log In
Log In
Cardiovascular and Gastrointestinal Drugs
-
Log In
Log In
Log In
Log In
Cardiovascular and Gastrointestinal Drugs Growth
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Taiwan
5.12B
Log In
Log In
Log In
Log In
Taiwan Growth
5.78%
Log In
Log In
Log In
Log In
Other Countries
391.78M
Log In
Log In
Log In
Log In
Other Countries Growth
-1.73%
Log In
Log In
Log In
Log In
America
381.29M
Log In
Log In
Log In
Log In
America Growth
43.50%
Log In
Log In
Log In
Log In
Europe
-
Log In
Log In
Log In
Log In
Europe Growth
-
Log In
Log In
Log In
Log In